Johnson & Johnson announced that it has successfully completed the acquisition ofV-WaveThe acquisition,V-WaveIs an innovative medical device company focused on developing innovative treatment solutions for heart failure patients. After the acquisition,V-WaveWill operate as part of Johnson & Johnson.
V-WaveCore ProductVentura Interatrial ShuntReceived CE approval for marketing in 2020 and was granted the "Breakthrough Device" designation by the FDA.
Executive Evaluation
"We are delighted to officially welcome V-Wave to Johnson & Johnson Medical. V-Wave's new implantable deviceDevice---Ventura Interatrial Shunt Offers Great Hope for Heart Failure Patients with Reduced Ejection Fraction. This technology has the potential...To be the first device of its kind to reach the market. We look forward to collaborating with the talented V-Wave team to bring this transformative innovation to patients.
---Tim Schmid Executive Vice President and Global Chairman of Johnson & Johnson Medical TechnologyAcquisitionV-WaveFollowing this, Johnson & Johnson strengthened its position in the cardiovascular disease field and provided a greater opportunity to address heart failure, one of the most pressing unmet medical needs in today’s healthcare landscape.It further acceleratesJohnson & JohnsonThe shift towards high-growth and high-opportunity markets, complemented by a comprehensive medical technology portfolio with leading platforms addressing coronary artery disease, peripheral artery disease, cardiac rehabilitation, and atrial fibrillation.V-WaveThis will further strengthen Johnson & Johnson's relationships with structural interventional cardiologists and heart failure specialists, and will benefit more than 800,000 heart failure patients annually in the U.S. (HFrEF) Provide patients with new treatment (solve previousUnmet Clinical Needs）。
Ventura Interatrial Shunt Ventura Interatrial ShuntIt is a new type of hourglass-shaped implant, whichThere is a small opening in the middle, allowing blood to flow from the left atrium to the right atrium.
V-Wave Ventura ShuntThe novel hourglass design is intended to create a similar effect from the high-pressure atrium to the low-pressure atrium.WenThe effect of the Venturi tube.This effect enhances the efficiency of blood transfer, allowing the shunt to be performed.GetSmaller.A Venturi tube is a pipe that first contracts and then gradually expands., which can generate the Venturi effect.That is, when the restricted flow passes through a narrowed cross-sectional area, the fluid velocity increases, and the velocity is inversely proportional to the cross-sectional area. Generally speaking, this effect refers to the phenomenon where high-speed flowing fluid creates a low-pressure area nearby, resulting in suction. This effect can be utilized to create a Venturi tube.
V-Wave Ventura ShuntDesign FeaturesHourglass Stent (Nitinol): Designed to securely anchor the shunt device to the fossa ovalis, preventing migration or embolization of the shunt.
Membrane (ePTFE): Aimed at restricting tissue growth and maintaining shunt patency.
Ventura Interatrial Shunt Demonstration
V-WaveFounded in Israel in 2009, focused on developing percutaneous implantable technologies for patients with chronic heart failure.V-WaveDesign technology, with itsVentura Interatrial ShuntFocusing on helping heart failure patients alleviate symptoms, reduce hospitalization, and improve quality of life.
